Today researchers said they have developed a simple blood test that could help identify Alzheimer’s patients years before they have any major symptoms.
A story that read like an ad, appeared to draw big chunks from a company news release, and didn’t give men the whole picture they need to evaluate a new test.
Researchers at Stanford University have developed a potentially pathbreaking blood test that, according to preliminary studies, is able to identify patients with Alzheimer’s disease – an ailment that has been notoriously difficult to diagnose.
The story’s suggestion that the spinal fluid analysis used in the study is 100 percent accurate is, in fact, inaccurate. (The "can be 100% accurate" phrase is misleading and unhelpful.) The specificity of the test – about 1/3 of those who tested positive had no evidence of Alzheimer’s – is a big issue.
An interesting and fairly informative piece about male infertility with a news hook based on a new fertility test.
A provocative new theory suggests that one root cause of Alzheimer’s disease is linked to diabetes â€” a theory about to be tested in thousands of Alzheimer’s patients given the diabetes drug Avandia in hopes of slowing brain decay.
Solid medical conference reporting, with many expert interviews and good context provided. Goes far beyond the conference presentation itself.
This is an important area of research, but inadequately explained in this story.
The FDA approved a new gene test Tuesday to help predict whether women diagnosed with early stage breast cancer will relapse in five or 10 years.
There are multiple ways to search our reviews. You may search by keyword, news source or review rating.